09:53 AM EST, 02/18/2025 (MT Newswires) -- PAVmed ( PAVM ) said Tuesday it regained compliance with Nasdaq's continued listing standards for primary equity securities.

The medical technology company said it received a notification on Friday from Nasdaq stating its securities will continue to be listed and traded on the stock exchange.

PAVmed ( PAVM ) will be under a mandatory panel monitor for one year, during which any failure to meet stockholders' equity requirements will trigger a delisting notice, requiring immediate action and possibly a new hearing, the company said.

Shares of PAVmed ( PAVM ) were up nearly 6% in recent Tuesday trading.

Price: 0.84, Change: +0.05, Percent Change: +5.95